Studies suggest aspirin may help slow the spread of certain ... research is needed before aspirin can be recommended for cancer prevention Regular aspirin use has been associated with a reduced ...

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.

A new study reveals that aspirin can reduce cancer metastasis by stimulating the immune system. Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell ...

A summary of human trials does suggest that Aspirin reduces the incidence of colon polyps. But when it comes to cancer prevention, the data is more nuanced. The Physicians’ Health Study ...

The scientists caution that, in some people, aspirin can have serious side-effects and clinical trials are underway to determine how to use it safely and effectively to prevent cancer spread ...

The investigators note that further studies to address the risk–benefit profile of long-term aspirin or NSAID use in various risk groups, compared with other potential cancer prevention ...

For decades, aspirin has been known as a go-to painkiller. New research reveals how it may also help fight cancer. While previous research hinted at a link between aspirin use and improved cancer ...

Aspirin prevents blood clots by stopping thrombocytes, also called platelets, from clumping together. Current research suggests aspirin may have another pharmacological benefit — the prevention of ...

The findings could support the ongoing clinical trials and pave the way for more targeted use of aspirin in cancer treatment. This discovery can also now contribute to developing new drugs which ...

Lucy Notarantonio is Newsweek's Senior Lifestyle and Trends Reporter, based in Birmingham, UK. Her focus is trending stories and human interest features ranging from health, pets and travel.

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT ...